Advertisement

Topics

$CLSN 2H18: OVATION I final PFS data YE18:OVATION II translational data from first cohort Mid-2019: Phase 3 OPTIMA interim efficacy readout (118 events) 2019: Periodic data updates from OVATION II (Phase 2 open-label randomized study) YE19: Phase 3 OPTIMA

20:11 EDT 14 Sep 2018 | tgtxdough

2H18: OVATION I final PFS data YE18:OVATION II translational data from first cohort Mid-2019: Phase 3 OPTIMA interim efficacy readout (118 events) 2019: Periodic data updates from OVATION II (Phase 2 open-label randomized study) YE19: Phase 3 OPTIMA 2nd interim efficacy

Original Article: $CLSN 2H18: OVATION I final PFS data YE18:OVATION II translational data from first cohort Mid-2019: Phase 3 OPTIMA interim efficacy readout (118 events) 2019: Periodic data updates from OVATION II (Phase 2 open-label randomized study) YE19: Phase 3 OPTIMA

NEXT ARTICLE

More From BioPortfolio on "$CLSN 2H18: OVATION I final PFS data YE18:OVATION II translational data from first cohort Mid-2019: Phase 3 OPTIMA interim efficacy readout (118 events) 2019: Periodic data updates from OVATION II (Phase 2 open-label randomized study) YE19: Phase 3 OPTIMA"

Advertisement
Quick Search
Advertisement
Advertisement